Overview
Nathalie Wizla practices practicing medicine in Lille, France.
Ms. Wizla is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Cystic Fibrosis and Exocrine Pancreatic Insufficiency.
She is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Nathalie Wizla
Is Nathalie Wizla a top-rated expert for Cystic Fibrosis?
MediFind is an objective health platform that identifies experts based on real-world data. Nathalie Wizla is classified as an Advanced expert for Cystic Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nathalie Wizla participate in research or clinical trials?
Yes. Nathalie Wizla has published 13 articles and abstracts on conditions like Cystic Fibrosis. You can view a list of Nathalie Wizla's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cystic FibrosisMs. Wizla isAdvanced. Learn about Cystic Fibrosis.
- Experienced
- Exocrine Pancreatic InsufficiencyMs. Wizla isExperienced. Learn about Exocrine Pancreatic Insufficiency.